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Hypoxia-inducible factorErythropoietin production has been reported to occur in the peritubular interstitial ﬁbroblasts in the kid-
ney. Since the erythropoietin production in the nephron is controversial, we reevaluated the erythropoi-
etin production in the kidney. We examined mRNA expressions of erythropoietin and HIF PHD2 using
high-sensitive in situ hybridization system (ISH) and protein expression of HIF PHD2 using immunohis-
tochemistry in the kidney. We further investigated the mechanism of erythropoietin production by
hypoxia in vitro using human liver hepatocell (HepG2) and rat intercalated cell line (IN-IC cells). ISH in
mice showed mRNA expression of erythropoietin in proximal convoluted tubules (PCTs), distal convo-
luted tubules (DCTs) and cortical collecting ducts (CCDs) but not in the peritubular cells under normal
conditions. Hypoxia induced mRNA expression of erythropoietin largely in peritubular cells and slightly
in PCTs, DCTs, and CCDs. Double staining with AQP3 or AE1 indicated that erythropoietin mRNA
expresses mainly in b-intercalated or non a/non b-intercalated cells of the collecting ducts. Immunohis-
tochemistry in rat showed the expression of HIF PHD2 in the collecting ducts and peritubular cells and its
increase by anemia in peritubular cells. In IN-IC cells, hypoxia increased mRNA expression of erythropoi-
etin, erythropoietin concentration in the medium and protein expression of HIF PHD2. These data suggest
that erythropoietin is produced by the cortical nephrons mainly in the intercalated cells, but not in the
peritubular cells, in normal hematopoietic condition and by mainly peritubular cells in hypoxia, suggest-
ing the different regulation mechanism between the nephrons and peritubular cells.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Erythropoietin, which was initially puriﬁed from the urine, has
a major role in erythrocyte production [1]. Severe anemia stimu-
lates erythropoietin production by 500-fold, and more than 90%
of erythropoietin mRNA is found in the kidney of anemic mice
[2]. The site of erythropoietin production in the kidney has been
a matter of concern. Most studies have reported that interstitial
ﬁbroblasts are the site of erythropoietin production in the kidney[3–12]. A few papers have reported that erythropoietin is produced
in the proximal or distal tubules [13,14]. Erythropoietin production
is stimulated by hypoxia through the activation of hypoxia-induc-
ible transcription factors (HIF) [15–17]. Functional anemia achieved
by 0.1% carbon monoxide administration increased HIF1a expres-
sion in most of the nephron segments and the interstitial cells,
and cobaltous chloride, which mimics hypoxia, increased HIF1a
expression in the distal tubules, collecting ducts and interstitial
cells [9,18,19]. In contrast, carbonmonoxide and cobaltous chloride
increased HIF2a expression only in interstitial cells, which suggests
that HIF2a-expressing interstitial ﬁbroblasts are the only renal cells
that produce erythropoietin under hypoxia [9,18,19]. Further
examinations distinguished renal erythropoietin-producing (REP)
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reports, mice were subjected to really severe anemia (14–17%,
12%, less than 10%, and less than 15% in hematocrit in Ref. [3, 4, 6,
12], respectively) to show REP cells in the kidney, questioning the
physiological role of REP cells for erythropoietin production. There
should be a site that produces erythropoietin to maintain erythro-
poiesis under basal condition. However, no report has shown such
site under basal condition so far.
Obara et al. reported that GATA transcription factors play a cru-
cial role in erythropoietin gene expression [12]. They suggested
that GATA2 and 3 are mainly expressed in the distal tubules and
collecting ducts and that they suppress erythropoietin production
at the transcriptional level. These data imply that the distal tubules
and collecting ducts are possible sites of erythropoietin production
among the nephron segments.
The purpose of our study was to evaluate whether the nephron
could produce erythropoietin. We used high sensitivity in situ
hybridization (ISH) to detect the mRNAs of erythropoietin and
HIF prolyl hydroxylase 2 (PHD2) and immunohistochemistry to
detect HIF PHD2. We also used IN-IC cells, which are characterized
as intercalated cells to study the mechanisms of erythropoietin
production by the nephron [20,21].2. Materials and methods
2.1. Animals and cell culture
C57BL/6J mice were used for ISH and Sprague Dawley (SD) rats
were used for immunohistochemistry. The intercalated cell line
(IN-IC cells) was generated as previously described [20,21]. HepG2
cells were purchased from RIKEN (Tsukuba, Japan). Anemia was
induced in the SD rats. HepG2 cells were cultured at 37 C in
DMEM with 10% FBS. Because IN-IC cells have the SV40 tempera-
ture-sensitive large T antigen, the cells were cultured at 33 C in
DMEM/F12 medium (Life Technologies Japan, Tokyo) with 10%
FBS, 10 lg/ml transferrin, 1 lg/ml insulin, 10 ng/ml EGF, 0.5 lg/
ml hydrocortisone, 6.5 ng/ml triiodo-tyronine and 1% penicillin/
streptomycin. In the hypoxia experiments, IN-IC and HepG2 cells
were incubated in 1% O2 for 24 h. All animal and cell experiments
were evaluated and approved by the Committee for Animal Exper-
imentation at the Hyogo College of Medicine (28036, 29014) and
Kitasato University Medical Center (25-2).2.2. In situ hybridization
4 h hypoxia (7% O2) was applied before the sacriﬁce of mice [22].
High sensitivity ISH was performed as described previously [23–
26]. In brief, total RNA of themouse kidney (BD Bioscience, Franklin
Lakes, USA) was reverse transcribed with an RNA PCR Kit (AMV),
ver.3.0 (Takara-Bio, Otsu, Japan), and the cRNA probe for erythro-
poietin (GenBank accession No. NM_007942) or HIF PHD2 (Gen-
Bank accession No. NM_053207) was generated with T7 promoter
region-tailed polymerase chain reaction (PCR) primers (Table 1).
The hybridized sections were successively treated with 0.1% avidin,Table 1
Primers used to generate a DNA template by RT-PCR for in vitro transcription.
Primer Forward
EPO
Sense probe 50-CTTAATACGACTCACTATAGGGTCTGCGACAGTCGAGTTC
Antisense probe 50- TCTGCGACAGTCGAGTTCTG-30
PHD2
Sense probe 50-CTTAATACGACTCACTATAGGGTGGCTCTGGAGTACATCG
Antisense probe 50-TGGCTCTGGAGTACATCGTG-30
RT-PCR, reverse transcription-polymerase chain reaction.0.01% biotin solution, 0.5% casein/TBS, the horseradish peroxidase
(HRP)-conjugated rabbit anti-DIG F (ab0) fragment antibody (Dako-
Cytomation, Glostrup, Denmark), biotinylated tyramide solution
and HRP-conjugated streptavidin (DakoCytomation). Staining was
visualized with the DAB Liquid System (Bio SB, Santa Barbara,
USA) and Mayer’s hematoxylin. Precise localization was deter-
mined using a double-staining techniquewith anti-AQP3 (Alomone
Labs, Jerusalem Israel) and AE1 (Alpha Diagnostic Intl., San Antonio,
USA) antibodies, which are markers of the principal and a interca-
lated cells, respectively. AEC staining was used for the detection of
AQP3 or AE1. Erythropoietin mRNA expression in PCT, medullary
thick ascending limbs (MTAL), DCT, intercalated cell (IC), and peri-
tubular cells (peritubular erythropoietin producing cells, PTEC) was
quantiﬁed as number of dots per cell.
The expression of erythropoietin and HIF PHD2 mRNAs was
analyzed using a Zeiss microscope equipped with mercury epiﬂuo-
rescence (Axioplan 2, Carl Zeiss, Jena, Germany) with a digital cam-
era (AxioCam MRc5, Carl Zeiss). Captured images were analyzed
using an image analysis system (AxioVision Rel. 4.6, Carl Zeiss).2.3. Western blot
Western blot analysis was performed as previously described
[20,21]. Protein (10–50 lg) from the kidney medulla or IN-IC cells
was used for SDS–PAGE. The antibodies against HIF PHD1, 2 and 3
were purchased from Santa Cruz (sc-46024, 271835, and 46030,
respectively). Primary and secondary antibodies were used at dilu-
tions of 1000–5000 and 100,000–200,000, respectively. The detec-
tion of the bands was performed by Enhanced Chemiluminescence
Advance or Prime (GE Healthcare) using LAS-4000 mini (Fuji Film,
Japan) in the Research Facilities in Hyogo College of Medicine and
in the Kitasato University Medical Center.2.4. Real time PCR, ELISA and immunohistochemistry
For the hypoxia experiments, IN-IC and HepG2 cells were incu-
bated either at 20 or 1% O2 for 24 h. Real time PCR of erythropoietin
was performed using primers from Applied Biosystems (erythro-
poietin; Rn01481376_m1, b-actin; Rn00667869). Erythropoietin
concentration in the medium or plasma was examined using an
ELISA kit (E90028Ra) from USCN Life science (Wuhan, China) and
by CLEIA (SRL, Tokyo, Japan), respectively.
SD rats (male, 200–250 g) were made anemic (less than 20% in
hematocrit). The kidneys from control and anemic rats were ﬁxed
with 1% paraformaldehyde for 60 min at room temperature. After
embedding the cells in parafﬁn, the sections were cut, rinsed and
treated with an EDTA solution (pH 9, Nichirei No. 415211, Tokyo,
Japan) at 95 C for 10 min for the antigen retrieval heating. The pri-
mary antibody against HIF PHD2 was used at dilutions of 1:50-200.
The same doses of mouse IgG were used for the negative control.
The secondary antibody was goat-anti mouse IgG. DAB was used
for the visualization of the primary antibody. Some of these steps
were performed by Applied Medical Research (Osaka, Japan).Reverse
TG-30 50-GTGGTATCTGGAGGCGACAT-30
50-CTTAATACGACTCACTATAGGGGTGGTATCTGGAGGCGACAT-30
TG-30 50-CGCATCTTCCATCTCCATTT-30
50-CTTAATACGACTCACTATAGGGCGCATCTTCCATCTCCATTT-30
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Fig. 1. Erythropoietin mRNA expression in basal and hypoxic states in the kidney. Erythropoietin mRNA expression was observed in the DCTs and CCDs and slightly in the
PCTs, OMCDs and MTALs under basal conditions (A–C). Hypoxia increased the expression in the peritubular cells largely and in the DCTs, CCDs and PCTs to some extent but
not in OMCDs and MTALs (E–G). Sense probe did not show any signal both in basal and anemic conditions (D and H, respectively). The arrows indicate erythropoietin mRNA in
the renal tubules but not in the peritubular cells.
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Statistical analyses between or among the samples were per-
formed using Student’s t-test or ANOVAwith multiple comparisons
(Dunnett’s test), as appropriate. P values <0.05 were considered
signiﬁcant, and IBM SPSS (IBM Japan, Tokyo) was used for the
analysis.
3. Results
3.1. Erythropoietin mRNA expression in the kidney
Using ISH, erythropoietin mRNAs were probed with antisense
and visualized as brown dot-like structures (Fig. 1A–C, E–G) while
sense probe did not show any signal (Fig. 1D and H). Erythropoietin
mRNA was highly expressed in some cells of the CCDs and slightly
expressed in the DCTs and PCTs in control mice (basal condition).
There was no erythropoietin mRNA in the interstitial cells under
the basal condition (Fig. 1A–C). In the hypoxic mice, the abundance
of erythropoietin mRNA was signiﬁcantly increased in the intersti-
tial cells in the cortex (Fig. 1D and E). The erythropoietin mRNA
expression in PCT, DCT, and CCD was also increased. Slight
erythropoietin mRNA expression was detected in outer medullaryA CEPO
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Fig. 2. Localization and quantitative analysis of erythropoietin mRNA expression in the k
CCDs that were not double-stained by anti-AQP3 and anti-AE1 antibodies (A and C, re
respectively). The arrows indicate erythropoietin mRNA in CCDs. Very little erythropoie
largely increased by hypoxia. (F) Erythropoietin mRNA expression was calculated as brow
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PCT, DCT and IC and huge increase in PTEC. ⁄p < 0.05 vs. basal condition, ⁄⁄p < 0.01 vs. bcollecting ducts (OMCDs) and medullary thick ascending limbs
(MTALs) in basal condition but it was not increased in hypoxic con-
ditions. Double staining with AQP3 (marker for principal cells) or
AE1 (marker for a intercalated cells) on the CCDs revealed that
erythropoietin mRNA is expressed in the cells that do not express
either AQP3 or AE1 (Fig. 2A–D, respectively), suggesting that the
cells are b or non-a/non-b intercalated cells. To quantitatively esti-
mate the site of erythropoietin production in the kidney, the dots
per cells in PCT, MTAL, DCT, intercalated cell, and peritubular cells
were counted. Plasma erythropoietin level was largely increased
by 4-h hypoxia (Fig. 2E). Erythropoietin production was observed
mainly in the intercalated cells among the nephron but not in peri-
tubular cells in the basal condition (Fig. 2F). Hypoxia stimulated
erythropoietin production largely in peritubular cells and slightly
in the nephron (Fig. 2F). Dots were observed 47.3 ± 0.3% of interca-
lated cells in control condition and 19.1 ± 1.3% of peritubular cells
in hypoxia. Mean dots were 1.6 ± 0.16 and 4.5 ± 0.3 in intercalated
cells and peritubular erythropoietin producing cells (PTEC), respec-
tively, in hypoxia. These data suggest that the intercalated cells are
the major sites of erythropoietin production in basal conditions.
Therefore, in the following experiments, the intercalated cell line
(IN-IC cells) was used to investigate the mechanisms of erythropoi-
etin production.CCD
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Fig. 3. Erythropoietin expression under basal and hypoxic conditions in HepG2 and IN-IC cells. The erythropoietin level in the medium was increased by hypoxia both in
HepG2 and IN-IC cells (A). Hypoxia increased the erythropoietin and erythropoietin receptor mRNA expression levels in IN-IC cells (B). Hypoxia increased PHD1 and 2 but not
PHD3 expressions in HepG2 cells and PHD2 but not PHD1 and 3 expressions in IN-IC cells (C). ⁄p < 0.05 vs. basal condition.
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In HepG2 cells, hypoxia increased the erythropoietin concentra-
tion in the medium from 24.0 ± 2.4 to 33.6 ± 5.4 pg/ml (ELISA)
(n = 5, p < 0.05) (Fig. 3A). In IN-IC cells, hypoxia increased the
erythropoietin concentration in the medium from 24.2 ± 1.9 to
33.6 ± 6.8 pg/ml (n = 6, p < 0.05) (Fig. 3A). Hypoxia also increased
erythropoietin mRNA expression by 4.94-fold (Fig. 3B).
Hypoxia induced HIF PHD2 expression in both the HepG2 and
IN-IC cells and induced HIF PHD1 expression in HepG2 but not
IN-IC cells. The expression of HIF PHD3 was not observed in either
the HepG2 or IN-IC cells (Fig. 3C).
3.3. HIF PHD2 expression by anemia
Because the increase in HIF PHD2 expression plays a crucial role
in the regulation of erythropoietin expression in IN-IC cells, PHD2
expression was examined by ISH (mice) and immunohistochemis-
try (rats). HIF PHD2 mRNA expression was observed in the PCTs,
DCTs and CCDs (Fig. 4A). HIF PHD2 protein expression was
observed in DCT and CCD but not in PCT in basal condition
(Fig. 4C and E).
Hypoxia stimulated HIF PHD2 mRNA expression in DCTs, CCDs
and peritubular cells but not in PCTs (Fig. 4B). Anemia increased
the PHD2 protein expression in peritubular cells but not in the
DCTs and CCDs (Fig. 4D and F).4. Discussion
The kidney is a major site of erythropoietin production. For the
last 25 years, interstitial ﬁbroblasts, but not the nephron, have
been proposed to be a site of erythropoietin production [3–
12,15,17]. The primary techniques used for the determination of
the erythropoietin production site in the kidney were ISH [3–7]
and the study of transgenic mice expressing truncated erythropoi-
etin tagged with GFP [10–12]. However, there is a paper that per-
formed the expression of erythropoietin in microdissected rat
nephron using RT-PCR [14]. The administration of cobalt chloride,
a mimic of hypoxia, is reported to induce erythropoietin mRNA
expression in PCT, cortical thick ascending limbs (CAL) and CCD
[14]. We think that because the sensitivity of ISH was not enough
25 years ago, mice need to be subjected to anemic plus hypoxic
condition to identify the site of erythropoietin production. Recent
reports used the GFP-tagged erythropoietin gene and suggested
the possibility that REP cells, such as ﬁbroblasts, are of an extra-
renal origin [10,11]. The major problem of these studies was that
they involved the induction of very severe anemia, in which the
hematocrit is at least less than 17% to observe the interstitial or
the REP cells [3,4,6,12]. These ﬁndings strongly make us question
the role of the REP cells for erythropoietin production in physiolog-
ical condition. In the present study, we successfully detected eryth-
ropoietin mRNA in normal and anemic mice using the high-
sensitivity ISH method. Our results indicate that erythropoietin
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Fig. 4. PHD2 mRNA and protein expression in controls and under anemic conditions. PHD2mRNA expression was observed in the DCTs, CCDs, and PCTs (A). Anemia increased
PHD2 mRNA expression in the DCTs, CCDs and peritubular cells (B). PHD2 protein expression was observed in the DCTs, CCDs but not in PCTs in basal condition (C and E).
Anemia stimulated PHD2 protein expression in the peritubular cells but not in DCTs and CCDs (D and F).
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ducts under normal conditions. Our methods showed strong signal
for erythropoietin mRNA in peritubular cells in hypoxic condition,
which is consistent with many previous reports. The stimulation of
erythropoietin mRNA in the intercalated cells and IN-IC cells by
hypoxia is small compared with large increase in peritubular cells
in our study and severe anemia-induced 500 fold increase in whole
body [2]. We propose that renal tubules contribute to erythropoi-
etin production mainly at basal and anemic or hypoxic conditions
slightly.
Not only showing the site of erythropoietin production, we
approached a new mechanism for its production in renal tubules.
Hypoxia stimulates HIF 1a and 2a expression [15–17]. HIF 2a is
thought to be crucial for the stimulation of erythropoietin produc-
tion in peritubular cells by hypoxia [9,18,19]. In contrast to HIF2a
expression in peritubular cells, renal tubules dominantly express
HIF1a. Hypoxia is also known to stimulate HIF PHD 1, 2 and 3, in
which HIF PHD2 is responsible for the degradation of HIF2a. In
the present study, we showed that hypoxia increased HIF PHD2
expression in HepG2 and IN-IC cells. ISH and immunohistochemis-
try analysis revealed the PHD2 expression in DCTs, CCDs, and peri-
tubular cells, although the increase in protein expression byanemia in DCT and CCD was not signiﬁcant. Considering the differ-
ent pattern of erythropoietin expression between in renal tubules
and peritubular cells in basal and hypoxia conditions, there could
be a different regulation mechanism of erythropoietin production
in renal tubules from peritubular cells.
In conclusion, our data showed that erythropoietin is constitu-
tively produced by the cortical nephrons but not in the peritubular
cells in normal hematopoietic condition. Severe anemia stimulates
its production mainly in peritubular cells and slightly in the neph-
ron. Regulation mechanism of erythropoietin production by the
nephron is different from that by peritubular ﬁbroblasts. Erythro-
poietin production by the peritubular ﬁbroblasts occurs only in
severe anemia and may not be physiologically important.
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